Page last updated: 2024-11-05

zolpidem and Somatoform Disorders

zolpidem has been researched along with Somatoform Disorders in 2 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hung, CI1
Wang, SJ1
Liu, CY1
Thome, J1
Ruchsow, M1
Rösler, M1
Becker, T1

Other Studies

2 other studies available for zolpidem and Somatoform Disorders

ArticleYear
Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder.
    Depression and anxiety, 2009, Volume: 26, Issue:6

    Topics: Adolescent; Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed

2009
[Zolpidem dependence and depression in the elderly].
    Psychiatrische Praxis, 1995, Volume: 22, Issue:4

    Topics: Aged; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; H

1995